| Sibaud V, Delord J, Chevreau C
Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon? [JOURNAL ARTICLE]
Target Oncol 2009 Nov 7.
Abstract | Full Citation | Find Related Articles |
| Sonpavde G, Hutson TE
Novel antiangiogenic agents in the treatment of refractory renal cell carcinoma. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S29-36.
Abstract | Full Citation | Find Related Articles |
| Chung EK, Stadler WM
Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S22-8.
Abstract | Full Citation | Find Related Articles |
| Bukowski RM
What role do combinations of interferon and targeted agents play in the first-line therapy of metastatic renal cell carcinoma? [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S14-21.
Abstract | Full Citation | Find Related Articles |
| Molina AM, Motzer RJ
Current algorithms and prognostic factors in the treatment of metastatic renal cell carcinoma. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S7-13.
Abstract | Full Citation | Find Related Articles |
| Flaherty KT
Where does the combination of sorafenib and interferon in renal cell carcinoma stand? [JOURNAL ARTICLE]
Cancer 2009 Nov 4.
Full Citation | Publisher Full Text | Find Related Articles |
| Reig M, Bruix J
Medical treatments: in association or alone, their roles and their future perspectives : The Western experience. [JOURNAL ARTICLE]
J Hepatobiliary Pancreat Surg 2009 Nov 5.
Abstract | Full Citation |
| Overkleeft EN, Goldschmeding R, van Reekum F, et al.
Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Full Citation | Publisher Full Text | Find Related Articles |
| Guillet M, Walter T, Scoazec JY, et al.
Sorafenib-Induced Bilateral Osteonecrosis of Femoral Heads. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Full Citation | Publisher Full Text | Find Related Articles |
| Preto A, Goncalves J, Rebocho AP, et al.
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. [JOURNAL ARTICLE]
BMC Cancer 2009 Oct 31; 9(1):387.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
